The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
trans-1-(4-(4-fluorophenoxy)cyclohexyl)-3-m-tolylurea ID: ALA3099995
PubChem CID: 59168679
Max Phase: Preclinical
Molecular Formula: C20H23FN2O2
Molecular Weight: 342.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)c1
Standard InChI: InChI=1S/C20H23FN2O2/c1-14-3-2-4-17(13-14)23-20(24)22-16-7-11-19(12-8-16)25-18-9-5-15(21)6-10-18/h2-6,9-10,13,16,19H,7-8,11-12H2,1H3,(H2,22,23,24)/t16-,19-
Standard InChI Key: NJTVNOSSPRFPDH-RUCARUNLSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
12.1055 -23.2765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1044 -24.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8191 -24.5166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5355 -24.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5326 -23.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8173 -22.8638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2505 -24.5146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9643 -24.1010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6793 -24.5124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9630 -23.2761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3930 -24.0988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1086 -24.5168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8203 -24.1068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8232 -23.2816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1083 -22.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3905 -23.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5385 -22.8706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2520 -23.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2474 -24.1067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9600 -24.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6763 -24.1097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6755 -23.2806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9623 -22.8703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3904 -24.5228 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.3896 -24.5157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
11 9 1 6
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 1 1
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
2 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.41Molecular Weight (Monoisotopic): 342.1744AlogP: 4.65#Rotatable Bonds: 4Polar Surface Area: 50.36Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.57CX Basic pKa: ┄CX LogP: 4.50CX LogD: 4.50Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.85Np Likeness Score: -1.49
References 1. Chen T, Takrouri K, Hee-Hwang S, Rana S, Yefidoff-Freedman R, Halperin J, Natarajan A, Morisseau C, Hammock B, Chorev M, Aktas BH.. (2013) Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase., 56 (23): [PMID:24261904 ] [10.1021/jm400793v ]